Lessons from Eurodiale

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue SUPPL. 1, 2012, Pages 21-26

  Schaper, N C ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amputation; Costs; Delivery of care; Diabetic foot ulcer; Infection; Peripheral arterial disease

Indexed keywords

HEMOGLOBIN A1C;

CAST APPLICATION; DEATH; DIABETES MELLITUS; DIABETIC FOOT; FOLLOW UP; FOOT; FOOT CARE; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HUMAN; LEG; LEG AMPUTATION; LEG ISCHEMIA; LEG REVASCULARIZATION; MEDICAL RECORD; NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SHOE; TOE; TREATMENT OUTCOME; WOUND HEALING;

DIABETIC FOOT; EUROPE; HUMANS; PROSPECTIVE STUDIES;

EID: 84856186305     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2266     Document Type: Review

References (37)

1. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-1724.
2. Boulton AJ. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 2004; 47: 1343-1353.
3. Schaper NC, Apelqvist J, Bakker K. The international consensus and practical guidelines on the management and prevention of the diabetic foot. Curr Diab Rep 2003; 3: 475-479.
4. Apelqvist J, Bakker K, van Houtum WH, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007). Diabetes Metab Res Rev 2008; 24(Suppl 1): S181-S187.
5. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet 2005; 366: 1725-1735.
6. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-228.
7. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990; 13: 513-521.
8. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999; 22: 157-162.
9. Akhtar S, Schaper N, Apelqvist J, Jude E. A review of the Eurodiale studies: what lessons for diabetic foot care? Curr Diab Rep 2011; 11: 302-309.
10. Margolis DJ, Kantor J, Berlin JA. Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis. Diabetes Care 1999; 22: 692-695.
11. Nabuurs-Franssen MH, Sleegers R, Huijberts MS, et al. Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care 2005; 28: 243-247.
12. Beckert S, Witte M, Wicke C, et al. A new wound-based severity score for diabetic foot ulcers: a prospective analysis of 1, 000 patients. Diabetes Care 2006; 29: 988-992.
13. Oyibo SO, Jude EB, Tarawneh I, et al. The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 2001; 18: 133-138.
14. Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcer related and person-related measures. Diabetes Care 2006; 29: 1784-1787.
15. Faglia E, Mantero M, Caminiti M, et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Int Med 2002; 252: 225-232.
16. Gershater MA, Löndahl M, Nyberg P, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 2009; 52: 398-407.
17. Krishnan S, Nash F, Baker N, Rayman G. Reduction in diabetic amputations over 11years in a defined UK population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care 2008; 31: 99-101.
18. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000; 16(Suppl 1): S75-S83.
19. Nabuurs-Franssen MH, Huijberts MS, Nieuwenhuijzen Kruseman AC, Willems J, Schaper NC. Health-related-quality-of-life of diabetic foot ulcer patients and their caregivers. Diabetologia 2005; 48: 1906-1910.
20. Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation. J Intern Med 1994; 235: 463-471.
21. Prompers L, Huijberts M, Apelqvist J, et al. Optimal organization of health care in diabetic foot disease: introduction to the Eurodiale study. Int J Low Extrem Wounds 2007; 6: 11-17.
22. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50: 18-25.
23. Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 2008; 51: 747-755.
24. van Battum P, Schaper N, Prompers L, et al. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med 2011; 28: 199-205.
25. Young MJ, McCardle JE, Randall LE, Barclay JI. Improved survival of diabetic foot ulcer patients 1995-2008: possible impact of aggressive cardiovascular risk management. Diabetes Care 2008; 31: 2143-2147.
26. Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report criteria for including patients in research studies. Diab Metab Res Rev 2004; 20: S90-S95.
27. Dolan NC, Liu K, Criqui MH, et al. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 2002; 25: 113-120.
28. Schaper NC, Andros G, Apelqvist J, et al. Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patient with diabetes and ulceration of the foot 2011. Diabetes Metab Res Rev 2012; 28(Suppl 1): 236-237.
29. Schaper NC, Andros G, Apelqvist J, et al. Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2012; 28(Suppl 1): 218-224.
30. Cavanagh PR, Bus SA. Off-loading the diabetic foot for ulcer prevention and healing. Vasc Surg 2010; 52(3 Suppl): 37S-43S.
31. Raymakers JT, Houben AJ, van der Heyden JJ, Tordoir JH, Kitslaar PJ, Schaper NC. The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb. Diabet Med 2001; 18: 229-234.
32. Schaper NC, Huijberts M, Pickwell K. Neurovascular control and neurogenic inflammation in diabetes. Diabetes Metab Res Rev 2008; 24(Suppl 1): S40-S44.
33. Schaper NC, Havekes B. Diabetes: impaired damage control. Diabetologia 2012; 55: 18-20.
34. Prompers L, Huijberts M, Apelqvist J, et al. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study. Diabet Med 2008; 25: 700-707.
35. Mueller MJ, Diamond JE, Sinacore DR, et al. Total contact casting in treatment of diabetic plantar ulcers: controlled clinical trial. Diabetes Care 1989; 12: 384-388.
36. Caravaggi C, Faglia E, De Giglio R, et al. Effectiveness and safety of a nonremovable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: a randomized study. Diabetes Care 2000; 23: 1746-1751.
37. Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia 2008; 51: 1826-1834.